AML3D Secures AU$1.69 Million ARCEMY X Order to Strengthen US Industrial Presence
AML3D Limited (ASX: AL3) has received an AU$1.69 million order from FasTech LLC for a large-scale ARCEMY X metal additive manufacturing system, marking another step in expanding its footprint across the United States. FasTech, located near the U.S. Navy’s Additive Manufacturing Center of Excellence in Virginia, supplies advanced manufacturing services to sectors including defense, aerospace, energy, and other high-demand industries.
The new system, supported by a 2.7-tonne positioner from AML3D’s existing fleet, is expected to be operational by the third quarter of FY2026. This order contributes to AML3D’s broader US growth strategy, which includes scaling ARCEMY systems and contract manufacturing to serve defense and industrial markets. With this installation becoming the ninth ARCEMY system deployed in the US, AML3D aims to showcase the advantages of its large-scale metal 3D printing technology across a wider range of industrial applications.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
AML3D Secures AU$1.69 Million ARCEMY X Order to Strengthen US Industrial Presence
AML3D Limited (ASX: AL3) has received an AU$1.69 million order from FasTech LLC for a large-scale ARCEMY X metal additive manufacturing system, marking another step in expanding its footprint across the United States. FasTech, located near the U.S. Navy’s Additive Manufacturing Center of Excellence in Virginia, supplies advanced manufacturing services to sectors including defense, aerospace, energy, and other high-demand industries.
The new system, supported by a 2.7-tonne positioner from AML3D’s existing fleet, is expected to be operational by the third quarter of FY2026. This order contributes to AML3D’s broader US growth strategy, which includes scaling ARCEMY systems and contract manufacturing to serve defense and industrial markets. With this installation becoming the ninth ARCEMY system deployed in the US, AML3D aims to showcase the advantages of its large-scale metal 3D printing technology across a wider range of industrial applications.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au